XAP044
CAS No. 196928-50-4
XAP044 ( —— )
产品货号. M27492 CAS No. 196928-50-4
XAP044 是一种 mGlu7 选择性拮抗剂,可抑制野生型小鼠脑切片中的外侧杏仁核长时程增强 (LTP),在 88 nm 处具有半最大阻断。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥662 | 有现货 |
|
| 5MG | ¥947 | 有现货 |
|
| 10MG | ¥1796 | 有现货 |
|
| 25MG | ¥3153 | 有现货 |
|
| 50MG | ¥4585 | 有现货 |
|
| 100MG | ¥6201 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥1159 | 有现货 |
|
生物学信息
-
产品名称XAP044
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述XAP044 是一种 mGlu7 选择性拮抗剂,可抑制野生型小鼠脑切片中的外侧杏仁核长时程增强 (LTP),在 88 nm 处具有半最大阻断。
-
产品描述XAP044 is a mGlu7-selective antagonist which inhibits lateral amygdala long term potentiation (LTP) in brain slices from wild type mice with a half-maximal blockade at 88 nm.(In Vitro):Previous study showed that in contrast to all previous mGlu7-selective drugs, XAP044 did not act through the seven-transmembrane region but rather via a binding pocket localized in mGlu7's extracellular Venus flytrap domain, a region identified for orthosteric agonist binding, which was suggested by the chimeric receptor studies in recombinant cell line assays .(In Vivo):In rodent behavioral paradigms, XAP044 demonstrated good brain exposure and wide spectrum anti-stress and antidepressant- and anxiolytic-like efficacy. In addition, XAP044 could reduce freezing during acquisition of Pavlovian fear and innate anxiety, which was consistent with the phenotypes of mGlu7-deficient mice. Moreover, XAP044 was able to inhibit lateral amygdala long term potentiation (LTP) in brain slices from wild type mice with a half-maximal blockade at 88 nm. It was alos found that there was no effect of XAP044 on LTP of mGlu7-deficient mice, suggesting that such pharmacological effect was mGlu7-dependent .
-
体外实验——
-
体内实验——
-
同义词——
-
通路Neuroscience
-
靶点GluR
-
受体TRPV1
-
研究领域——
-
适应症——
化学信息
-
CAS Number196928-50-4
-
分子量380.137
-
分子式C15H9IO4
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESOc1ccc2c(c1)occ(Oc1ccc(I)cc1)c2=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Alexander Stokes. Methods and compositions for prevention and treatment of cardiac hypertrophy. US10137123B2
产品手册
关联产品
-
GYKI 53655 hydrochlo...
GYKI 53655 (LY300168) hydrochloride 是 α-氨基-3-羟基-5-甲基异恶唑-4-丙酸 (AMPA) 的拮抗剂。
-
GLPG0634 analogue
GLPG0634(类似物)是一种特异性 JAK1 抑制剂,对 JAK1/2/3 和 TYK2 的 IC50 分别为 10/28/810/116 nM。
-
GW791343 3HCl
GW791343 HCl是GW791343的HCl盐形式,GW791343是人P2X7受体抑制剂的非竞争性变构调节剂,pIC50为7。
021-51111890
购物车()
sales@molnova.cn

